Report Overview
Endocrine therapy drugs are a class of drugs used to treat hormone-related diseases, mainly by regulating the level of hormones in the body or blocking the effects of hormones to achieve therapeutic effects. This type of drug is widely used to treat certain types of cancer (such as breast cancer and prostate cancer), thyroid diseases, diabetes, osteoporosis and other endocrine system diseases. The global Endocrine Therapy Medication market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the ?Endocrine Therapy Medication Industry Forecast? looks at past sales and reviews total world Endocrine Therapy Medication sales in 2023, providing a comprehensive analysis by region and market sector of projected Endocrine Therapy Medication sales for 2024 through 2030. With Endocrine Therapy Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocrine Therapy Medication industry. This Insight Report provides a comprehensive analysis of the global Endocrine Therapy Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endocrine Therapy Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Endocrine Therapy Medication market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocrine Therapy Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocrine Therapy Medication. United States market for Endocrine Therapy Medication is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Endocrine Therapy Medication is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Endocrine Therapy Medication is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Endocrine Therapy Medication players cover Maanshan Fengyuan Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Beijing Bornte Pharmaceutical Co., Ltd., Chengdu Tiantaishan Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. This report presents a comprehensive overview, market shares, and growth opportunities of Endocrine Therapy Medication market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Hormones and Related Drugs Hormone Antagonists and Related Drugs Segmentation by Application: Hospital Clinic Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Maanshan Fengyuan Pharmaceutical Co., Ltd. Shanghai Lizhu Pharmaceutical Co., Ltd. Zhongpeptide Biochemical Co., Ltd. Beijing Bornte Pharmaceutical Co., Ltd. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Shenzhen Hanyu Pharmaceutical Co., Ltd. Chongqing Laimi Pharmaceutical Co., Ltd. Changchun Jinsai Pharmaceutical Co., Ltd. Dandong Yichuang Pharmaceutical Co., Ltd. Good Doctor Pharmaceutical Group Co., Ltd. Yangtze River Pharmaceutical Group Co., Ltd. Zhejiang Haizhou Pharmaceutical Co., Ltd. Zhejiang Haizheng Pharmaceutical Co., Ltd. Shanghai Zhaohui Pharmaceutical Co., Ltd. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Eli Lilly and Company Pfizer Teva AstraZeneca Janssen Biotech Dr. Reddy's Cougar Biotechnology, Inc. Key Questions Addressed in this Report What is the 10-year outlook for the global Endocrine Therapy Medication market? What factors are driving Endocrine Therapy Medication market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Endocrine Therapy Medication market opportunities vary by end market size? How does Endocrine Therapy Medication break out by Type, by Application?
Table Of Contents
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2017-2029) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Endocrine Therapy Medication Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Endocrine Therapy Medication Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Endocrine Therapy Medication Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by region) 5 Global Endocrine Therapy Medication Market-Segmentation by Type 5.1 Type 1 5.2 Type 2 5.3 Type 3 6 Global Endocrine Therapy Medication Market-Segmentation by Application 6.1 Application 1 6.2 Application 2 6.3 Application 3 7 Global Endocrine Therapy Medication Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence A Company Profiles 8.1 Company 1 8.1.1 Company 1 Profile 8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023 8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis 8.1.4 Company 1 Business Overview/Recent Development/Acquisitions 8.2 Company 2 8.2.1 Company 2 Profile 8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023 8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis 8.2.4 Company 2 Business Overview/Recent Development/Acquisitions 8.3 Company 3 8.3.1 Company 3 Profile 8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023 8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis 8.3.4 Company 3 Business Overview/Recent Development/Acquisitions 8.4 Company 4 8.4.1 Company 4 Profile 8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023 8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis 8.4.4 Company 4 Business Overview/Recent Development/Acquisitions 8.5 Company 5 8.5.1 Company 5 Profile 8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023 8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis 8.5.4 Company 5 Business Overview/Recent Development/Acquisitions 8.6 Company 6 8.6.1 Company 6 Profile 8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023 8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis 8.6.4 Company 6 Business Overview/Recent Development/Acquisitions 8.7 Company 7 8.7.1 Company 7 Profile 8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023 8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis 8.7.4 Company 7 Business Overview/Recent Development/Acquisitions 8.8 Company 8 8.8.1 Company 8 Profile 8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023 8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis 8.8.4 Company 8 Business Overview/Recent Development/Acquisitions 8.9 Company 9 8.9.1 Company 9 Profile 8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023 8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis 8.9.4 Company 9 Business Overview/Recent Development/Acquisitions 8.10 Company 10 8.10.1 Company 10 Profile 8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023 8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis 8.10.4 Company 10 Business Overview/Recent Development/Acquisitions 8.11 Company 11 8.11.1 Company 11 Profile 8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023 8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis 8.11.4 Company 11 Business Overview/Recent Development/Acquisitions 8.12 Company 12 8.12.1 Company 12 Profile 8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023 8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis 8.12.4 Company 12 Business Overview/Recent Development/Acquisitions 8.13 Company 13 8.13.1 Company 13 Profile 8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023 8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis 8.13.4 Company 13 Business Overview/Recent Development/Acquisitions 8.14 Company 14 8.14.1 Company 14 Profile 8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023 8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis 8.14.4 Company 14 Business Overview/Recent Development/Acquisitions 8.15 Company 15 8.15.1 Company 15 Profile 8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023 8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis 8.15.4 Company 15 Business Overview/Recent Development/Acquisitions 9 Global Endocrine Therapy Medication Market-Segmentation by Geography 10 North America 10.1 North America Endocrine Therapy Medication Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 10.2 North America Endocrine Therapy Medication Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 10.3 North America Endocrine Therapy Medication Production Analysis from 2017-2023 10.4 North America Endocrine Therapy Medication Consumption Analysis from 2017-2023 10.5 North America Endocrine Therapy Medication Import and Export from 2017-2023 10.6 North America Endocrine Therapy Medication Value, Production and Market Share by Type (2017-2023) 10.7 North America Endocrine Therapy Medication Consumption, Value and Market Share by Application (2017-2023) 10.8 North America Endocrine Therapy Medication by Country (United States, Canada) 10.8.1 North America Endocrine Therapy Medication Sales by Country (2017-2023) 10.8.2 North America Endocrine Therapy Medication Consumption Value by Country (2017-2023) 10.9 North America Endocrine Therapy Medication Market PEST Analysis 11 Europe 11.1 Europe Endocrine Therapy Medication Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 11.2 Europe Endocrine Therapy Medication Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 11.3 Europe Endocrine Therapy Medication Production Analysis from 2017-2023 11.4 Europe Endocrine Therapy Medication Consumption Analysis from 2017-2023 11.5 Europe Endocrine Therapy Medication Import and Export from 2017-2023 11.6 Europe Endocrine Therapy Medication Value, Production and Market Share by Type (2017-2023) 11.7 Europe Endocrine Therapy Medication Consumption, Value and Market Share by Application (2017-2023) 11.8 Europe Endocrine Therapy Medication by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Endocrine Therapy Medication Sales by Country (2017-2023) 11.8.2 Europe Endocrine Therapy Medication Consumption Value by Country (2017-2023) 11.9 Europe Endocrine Therapy Medication Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Endocrine Therapy Medication Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 12.2 Asia-Pacific Endocrine Therapy Medication Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 12.3 Asia-Pacific Endocrine Therapy Medication Production Analysis from 2017-2023 12.4 Asia-Pacific Endocrine Therapy Medication Consumption Analysis from 2017-2023 12.5 Asia-Pacific Endocrine Therapy Medication Import and Export from 2017-2023 12.6 Asia-Pacific Endocrine Therapy Medication Value, Production and Market Share by Type (2017-2023) 12.7 Asia-Pacific Endocrine Therapy Medication Consumption, Value and Market Share by Application (2017-2023) 12.8 Asia-Pacific Endocrine Therapy Medication by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Endocrine Therapy Medication Sales by Country (2017-2023) 12.8.2 Asia-Pacific Endocrine Therapy Medication Consumption Value by Country (2017-2023) 12.9 Asia-Pacific Endocrine Therapy Medication Market PEST Analysis 13 Latin America 13.1 Latin America Endocrine Therapy Medication Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 13.2 Latin America Endocrine Therapy Medication Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 13.3 Latin America Endocrine Therapy Medication Production Analysis from 2017-2023 13.4 Latin America Endocrine Therapy Medication Consumption Analysis from 2017-2023 13.5 Latin America Endocrine Therapy Medication Import and Export from 2017-2023 13.6 Latin America Endocrine Therapy Medication Value, Production and Market Share by Type (2017-2023) 13.7 Latin America Endocrine Therapy Medication Consumption, Value and Market Share by Application (2017-2023) 13.8 Latin America Endocrine Therapy Medication by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Endocrine Therapy Medication Sales by Country (2017-2023) 13.8.2 Latin America Endocrine Therapy Medication Consumption Value by Country (2017-2023) 13.9 Latin America Endocrine Therapy Medication Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Endocrine Therapy Medication Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 14.2 Middle East & Africa Endocrine Therapy Medication Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 14.3 Middle East & Africa Endocrine Therapy Medication Production Analysis from 2017-2023 14.4 Middle East & Africa Endocrine Therapy Medication Consumption Analysis from 2017-2023 14.5 Middle East & Africa Endocrine Therapy Medication Import and Export from 2017-2023 14.6 Middle East & Africa Endocrine Therapy Medication Value, Production and Market Share by Type (2017-2023) 14.7 Middle East & Africa Endocrine Therapy Medication Consumption, Value and Market Share by Application (2017-2023) 14.8 Middle East & Africa Endocrine Therapy Medication by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Endocrine Therapy Medication Sales by Country (2017-2023) 14.8.2 Middle East & Africa Endocrine Therapy Medication Consumption Value by Country (2017-2023) 14.9 Middle East & Africa Endocrine Therapy Medication Market PEST Analysis 15 Future Forecast of the Global Endocrine Therapy Medication Market from 2023-2029 15.1 Future Forecast of the Global Endocrine Therapy Medication Market from 2023-2029 Segment by Region 15.2 Global Endocrine Therapy Medication Production and Growth Rate Forecast by Type (2023-2029) 15.3 Global Endocrine Therapy Medication Consumption and Growth Rate Forecast by Application (2023-2029) 16 Appendix 16.1 Methodology 16.2 Research Data Source